Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes

    ... 12, 2014 Myelodysplastic syndromes are a heterogeneous group of clonal bone marrow hematopoietic ...

    Research Article last updated 09/24/2014 - 10:41am.

  2. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity

    ... of inherited bone marrow failure and inherited myelodysplastic syndromes is essential to guide clinical management. Distinguishing ...

    Research Article last updated 10/02/2014 - 10:20am.

  3. Treatment of low-risk myelodysplastic syndromes

    ... The majority of myelodysplastic syndrome (MDS) patients belong to the International ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 01/26/2017 - 10:42am.

  4. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... of these, 311 patients had a concomitant coded diagnosis of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Eighty-six ... acute myeloid leukemia (AML) myelodysplastic syndromes (MDS) ...

    Research Article last updated 02/03/2017 - 1:25pm.

  5. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly

    ... 1, 2016 Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic diseases ...

    Research Article last updated 12/09/2015 - 1:30pm.

  6. Infections in myelodysplastic syndromes: a review

    ... June 24, 2012 Myelodysplastic syndromes are associated with a risk of severe infections. While ...

    Research Article last updated 07/31/2012 - 1:39pm.

  7. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

    ... allogeneic stem cell transplantation (SCT) treatment in myelodysplastic syndromes (MDS). However, patient cohorts are often heterogeneous by ...

    Research Article last updated 10/06/2016 - 11:40am.

  8. Assessing Quality of Care for the Myelodysplastic Syndromes

    ... especially for heterogeneous malignancies such as the myelodysplastic syndromes (MDS). Recent work suggests that improvements may be needed in ...

    Research Article last updated 09/13/2016 - 2:41pm.

  9. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes

    ... decitabine are both approved for treatment of myelodysplastic syndromes (MDS) in the USA. In Europe, decitabine is not approved due to ...

    Research Article last updated 10/06/2016 - 11:34am.

  10. Hematopoietic Cell Transplantation for Myelodysplastic Syndromes

    ... (HCT) offers the only potential cure for patients with myelodysplastic syndromes (MDS). However, with current approaches to HCT, many older ...

    Research Article last updated 10/06/2016 - 1:59pm.